Oppenheim's myatonia

Myatonia Openheiam is a rare hereditary disease that manifests itself in impaired muscle function. It occurs due to a genetic mutation that affects the production of proteins in the body. Such proteins are essential for the proper functioning of muscles and nerves.

The disease manifests itself as pain and weakness in the muscles, especially in the neck and shoulders, as well as in the arms. Patients may have difficulty turning their head, raising their arms or toes, and may experience disturbances in gait and balance.

Symptoms may appear from childhood or even adolescence. They progress over time and can become more severe as the disease progresses. Myatonia can be diagnosed in both men and women, but is more common in children and young people under 30 years of age.

Treatment for Opengeyema myatonia may include both drug therapy and surgery. Some patients may find relief from Botox injections into the muscles to reduce soreness and weakness. But in severe cases, surgery may be required to change the shape and size of the muscles or remove them completely.

Myatonia Openheisema occurs due to gene mutations that affect the synthesis of muscle proteins. Some people with this disease have a mutation in the MYH7 gene. In some cases, this mutation can lead to the inability of muscles to contract due to a lack of protein production. This prevents the muscles from contracting and reduces mobility.